How Piperacillin/Tazobactam works in pregnant women and newborns
Part of Genetic & congenital, Infections clinical trials.
This study looks at how the antibiotic Piperacillin/Tazobactam moves through the body of pregnant women and their newborns. It may help doctors decide the best dose to prevent infections in babies at risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You are pregnant and your baby is at high risk of getting an infection shortly after birth.
- You are taking (or plan to take) the antibiotic Piperacillin/Tazobactam to prevent or treat infection.
- You must not have had a serious allergic reaction to this antibiotic before.
- You cannot be taking any other experimental medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares giving antibiotics to all preterm babies at risk of infection versus giving them only if symptoms develop. It aims to find out if waiting is safer and reduces unnecessary antibiotic use.
This study checks if a blood test (presepsin) can help doctors safely stop antibiotics earlier in preterm babies at moderate risk of infection. The goal is to reduce unnecessary antibiotic use.
This study looks at the best way to give the antibiotic piperacillin-tazobactam (Zosyn) to people 65 and older who have pneumonia. It aims to make treatment more effective and safer for older adults.
This trial compares two common antibiotics, meropenem and piperacillin/tazobactam, to see which works better for adults with sepsis who are critically ill. It aims to help doctors choose the best treatment for serious infections.
This study looks at how different types of sepsis affect treatment with the antibiotic piperacillin/tazobactam in patients with severe pneumonia. Researchers hope to find better ways to treat each person based on their specific condition.
This study compares a new way of giving the antibiotic piperacillin/tazobactam: a shot under the skin every few hours instead of through an IV line. It is for hospital patients with severe infections who need this medicine continuously.
Hear when a new Early-Onset Neonatal Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.